Skip to content
2000
Volume 7, Issue 2
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Over the last two decades, using PET imaging to assess changes in endogenous dopamine has become a standard neurochemical research technique. Initially, investigators focused on the in vivo study of direct pharmacological manipulation of the dopamine system (e.g., amphetamine, cocaine, methylphenidate). More recently, there has been a shift toward studying the role that dopamine plays in cognitive processes and in response to commonly used drugs with subtler effects on the dopamine system. Here, we outline the conceptual foundations of using PET to assess alterations in brain dopamine, and provide the reader with important theoretical constructs that must be addressed when designing such studies. Data from recent work with dopaminergic PET ligands are used to provide concrete examples of relevant design considerations.

Loading

Article metrics loading...

/content/journals/cmir/10.2174/157340511795445694
2011-05-01
2025-09-28
Loading full text...

Full text loading...

/content/journals/cmir/10.2174/157340511795445694
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test